J. Witztum
Genetics · 2001–2021
A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Genetics — 11 citations into it
Whom J. Witztum trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Witztum overall
Papers from J. Witztum's perspective
Ordered by how strongly the researchers J. Witztum trusts endorse each paper. Same corpus, a different order for every researcher.
- Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. (Journal of Biological Chemistry)
- Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. (Science)
- Role of LXRs in control of lipogenesis. (Genes & Development)
- Generation of C-reactive protein and complement components in atherosclerotic plaques. (American Journal of Pathology)
- Searching for genetic determinants in the new millennium (Nature)
- Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis (Circulation Research)
- Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice
- Vitamin E supplementation and cardiovascular events in high-risk patients. (New England Journal of Medicine)
- High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults: Evidence From Intravascular Ultrasound (Circulation)
- Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. (American Journal of Pathology)
Their papers
- Oxidation-Specific Epitopes are Danger Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate Immunity (2011) — 641 citations
- Innate and acquired immunity in atherogenesis (2002) — 706 citations
- Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL (2003) — 782 citations
- Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. (2021) — 657 citations
- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. (2020) — 825 citations
- RNA-Targeted Therapeutics. (2018) — 700 citations
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. (2016) — 686 citations
- Oxidative damage in multiple sclerosis lesions (2011) — 731 citations
- Lipoprotein Management in Patients With Cardiometabolic Risk (2008) — 829 citations
- Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. (2005) — 766 citations
- Atherosclerosis The Road Ahead (2001) — 3,161 citations